Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Sight Sciences, Inc.

SGHTNASDAQ
Healthcare
Medical - Devices
$3.67
$0.05(1.38%)
U.S. Market opens in 10h 17m

Sight Sciences, Inc. Fundamental Analysis

Sight Sciences, Inc. (SGHT) shows weak financial fundamentals with a PE ratio of -5.04, profit margin of -49.67%, and ROE of -55.72%. The company generates $0.1B in annual revenue with weak year-over-year growth of -1.47%.

Key Strengths

Cash Position47.21%
PEG Ratio-0.30
Current Ratio10.22

Areas of Concern

ROE-55.72%
Operating Margin-47.96%
We analyze SGHT's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -71.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-71.6/100

We analyze SGHT's fundamental strength across five key dimensions:

Efficiency Score

Weak

SGHT struggles to generate sufficient returns from assets.

ROA > 10%
-33.33%

Valuation Score

Excellent

SGHT trades at attractive valuation levels.

PE < 25
-5.04
PEG Ratio < 2
-0.30

Growth Score

Weak

SGHT faces weak or negative growth trends.

Revenue Growth > 5%
-1.47%
EPS Growth > 10%
9.65%

Financial Health Score

Excellent

SGHT maintains a strong and stable balance sheet.

Debt/Equity < 1
0.63
Current Ratio > 1
10.22

Profitability Score

Weak

SGHT struggles to sustain strong margins.

ROE > 15%
-5571.57%
Net Margin ≥ 15%
-49.67%
Positive Free Cash Flow
No

Key Financial Metrics

Is SGHT Expensive or Cheap?

P/E Ratio

SGHT trades at -5.04 times earnings. This suggests potential undervaluation.

-5.04

PEG Ratio

When adjusting for growth, SGHT's PEG of -0.30 indicates potential undervaluation.

-0.30

Price to Book

The market values Sight Sciences, Inc. at 3.03 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.03

EV/EBITDA

Enterprise value stands at -6.80 times EBITDA. This is generally considered low.

-6.80

How Well Does SGHT Make Money?

Net Profit Margin

For every $100 in sales, Sight Sciences, Inc. keeps $-49.67 as profit after all expenses.

-49.67%

Operating Margin

Core operations generate -47.96 in profit for every $100 in revenue, before interest and taxes.

-47.96%

ROE

Management delivers $-55.72 in profit for every $100 of shareholder equity.

-55.72%

ROA

Sight Sciences, Inc. generates $-33.33 in profit for every $100 in assets, demonstrating efficient asset deployment.

-33.33%

Following the Money - Real Cash Generation

Operating Cash Flow

Sight Sciences, Inc. generates limited operating cash flow of $-30.21M, signaling weaker underlying cash strength.

$-30.21M

Free Cash Flow

Sight Sciences, Inc. generates weak or negative free cash flow of $-30.44M, restricting financial flexibility.

$-30.44M

FCF Per Share

Each share generates $-0.56 in free cash annually.

$-0.56

FCF Yield

SGHT converts -15.31% of its market value into free cash.

-15.31%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-5.04

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.30

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.03

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.55

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.63

vs 25 benchmark

Current Ratio

Current assets to current liabilities

10.22

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.56

vs 25 benchmark

ROA

Return on assets percentage

-0.33

vs 25 benchmark

ROCE

Return on capital employed

-0.36

vs 25 benchmark

How SGHT Stacks Against Its Sector Peers

MetricSGHT ValueSector AveragePerformance
P/E Ratio-5.0428.25 Better (Cheaper)
ROE-55.72%780.00% Weak
Net Margin-49.67%-20122.00% (disorted) Weak
Debt/Equity0.630.30 Weak (High Leverage)
Current Ratio10.224.66 Strong Liquidity
ROA-33.33%-14687.00% (disorted) Weak

SGHT outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Sight Sciences, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

129.44%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-33.55%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

40.03%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ